RENTSCHLER
LIVE

Serial Number

79303647

Owner

Dr. Rentschler Holding GmbH & Co.KG

Attorney

Laken E. Adkins

Filing Date

Oct 5, 2020

Add to watchlist:

No watchlists yet
View on USPTO

RENTSCHLER Trademark

Serial Number: 79303647 • Registration: 6674479

RENTSCHLER is a trademark filed by Dr. Rentschler Holding GmbH & Co.KG on October 5, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Dr. Rentschler Holding GmbH & Co.KG (2 trademarks)

Lange Str. 35

Entity Type: 99

Trademark Details

Filing Date

October 5, 2020

Registration Date

March 22, 2022

Published for Opposition

January 4, 2022

Goods & Services

Chemical preparations for use in industry; chemicals used in science; chemicals used in photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; chemicals used in agriculture, horticulture and forestry, namely, seed treatment chemicals; fertilizing preparations; chemical substances for preserving foodstuffs; chemical reagents for scientific purposes, other than for medical or veterinary purposes; Laboratory diagnostics, namely, antibodies in the nature of antibody reagents used for the detection of antigens in cell and tissue analysis, for scientific purposes, namely, in vitro diagnostic use; diagnostics for scientific purposes, namely, diagnostic reagents for scientific use, diagnostic preparations used in science; detergents for industrial use, namely, detergents for use in manufacturing processes, detergents used for biopharmaceutical formulation, detergents used in gene and cell therapy as part of manufacturing processes; reagent paper and strips, other than for medical or veterinary purposes; chemically sensitized paper, foils and films, namely, photographic paper, X-ray films, sensitized but not exposed; media for chromatography, namely, chromatography chemicals in the nature of buffers, solvents, eluents, regeneration solutions, equilibration solutions, standards solutions; separation media for chromatography, namely, buffers, solvents, eluents, regeneration solutions, equilibration solutions, standards solutions for separation of a mixture into components; carrier materials, namely, diatomaceous earth for use as a chemical carrier, microscopic carrier beads with chemically attached DNA fragments for use in testing the operation of equipment for analyzing air for the presence of harmful biological substances, especially suitable for immunochromatography; testing kits for scientific purposes for analysis and diagnostics, predominantly consisting of reagents for scientific and research use, and enzyme-linked immunosorbent assays (ELISA) tests for scientific or research use; chemical markers and labels in the nature of chemically activated adhesive labels for sensing the presence of biochemical reactions for scientific purposes, and reagents for biochemical reactions for non-medical purposes; proteins for use in manufacture, the food industry, veterinary industry, diagnostic industry, laboratory use, other than medical and veterinary purposes, scientific and research purposes, industrial applicability purposes; serum proteins, for use in manufacture, the food industry, veterinary industry, diagnostic industry, laboratory use, other than medical and veterinary purposes, scientific and research purposes, industrial applicability purposes; peptides for use in manufacture, the food industry, veterinary industry, diagnostic industry, laboratory use, other than medical and veterinary purposes, scientific and research purposes, industrial applicability purposes; nucleic acids/nucleotides for use in manufacture, the pharmaceutical industry, the food industry, veterinary industry, diagnostic industry, laboratory use, other than medical and veterinary purposes, scientific and research purposes, industrial applicability purposes; hormones in the nature of plant hormones (phytohormones), hormones for hastening ripening of fruit, as well as enzymes for scientific and research purposes and industrial applicability purposes

Medical services; medical assistance; animal healthcare services; consultancy and information services relating to biopharmaceutical products, namely, providing medical information and pharmaceutical consultation in the nature of a medical consultation relating to biopharmaceutical products

Pharmaceuticals, namely, oncological biopharmaceuticals, ocular pharmaceuticals, antibacterial pharmaceuticals, anti-viral biopharmaceuticals, vaccines; veterinary preparations, namely, antioxidants, enzyme preparations for veterinary purposes, for humane enzyme preparations; preparations for medical purposes, namely, bath preparations for medical purposes, diagnostic preparations for medical purposes; dietetic substances in the nature of dietetic preparations adapted for medical purposes; infant formula; plasters for medical purposes, materials for dressings, namely, wound dressings, surgical dressings; dressings, medical; prophylactics, namely, tooth prophylactics, cerebral hemorrhage prophylactic agents; teeth filling material and dental impression materials for medical purposes; disinfectants; diagnostic preparations for medical or veterinary purposes; diagnostics in the nature of diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; x-ray contrast agents; sanitary articles for women, namely, sanitary napkins, sanitary tampons, sanitary preparations for medical use; diapers, namely, incontinence diapers, baby diapers, adult diapers; adhesives for dentures; dental mastics; medicinal herb infusions and medicated chewing gum; detergents for medical purposes; medicated oral care preparations in the nature of medicated toothpaste, medicated oral care gels; hair care and skin care preparations; pharmaceutical, veterinary or diagnostic preparations and substances produced by biochemical and/or genetic engineering methods, namely, sterilizing substances, radioactive substances for medical purposes, pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; chemical reagents for medical purposes; tests and test kits for medical and pharmaceutical purposes, predominantly consisting of chemical reagents and analyzers for medical diagnostic testing and analysis of body fluids; deodorizing preparations for household, commercial or industrial use for pet litter boxes, carpets; all purpose deodorizing preparations for household, commercial or industrial use; deodorizing cleaning preparations; air deodorizing preparations; hormones

Scientific and technological services, namely, scientific research, analysis, testing and development in the field of biomanufacturing and in the pharmaceutical field and research and design relating thereto; scientific and technological services, namely, research and design in the field of pharmaceutical research and development and diagnostics; industrial analysis in the nature of analysis of industrial fluids, industrial x-ray inspection services and industrial research services in the field of industrial fluids and industrial x-ray research; chemistry services and biochemical services, namely, chemistry consultation, biochemistry consultation, research in the fields of chemistry and biochemistry; services of medical, bacteriological and chemical laboratories; research in the medical field; research in the biochemical field; development of pharmaceutical, veterinary and diagnostic products and substances and methods for the manufacture thereof, in particular using biotechnological and genetically-engineered means, in the nature of research in the field of manufacturing machinery for pharmaceutical, veterinary and diagnostic products and substances, design and development of computer hardware for the pharmaceutical, veterinary and diagnostic products and substances manufacturing industries; technical consultancy in the fields of pharmaceutical research and development, veterinary preparations research and development and laboratory diagnostics sector; quality control for others

Custom manufacture of pharmaceutical, veterinary and diagnostic preparations and substances by pharmaceutical compounders; custom manufacture of biopharmaceuticals by pharmaceutical compounders; processing of biopharmaceutical materials for others in the nature of biomanufacturing of biopharmaceuticals using biological organisms in the manufacturing process, treatment of biopharmaceutical materials by means of chemical or biochemical processing, cryogenic processing; consultancy services relating to manufacturing processes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 19, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Mar 12, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 5, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 12, 2022 FICS
FINAL DISPOSITION PROCESSED
Aug 12, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 22, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 22, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 4, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 4, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Jan 1, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 15, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 15, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 15, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 30, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 27, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 27, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 27, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 27, 2021 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 21, 2021 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 21, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 17, 2021 TROA
REFUSAL PROCESSED BY IB
Apr 5, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 17, 2021 RFCS
REFUSAL PROCESSED BY MPU
Mar 17, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 12, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 11, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 4, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 13, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 4, 2021 REPR